Basic Information
| LncRNA/CircRNA Name | SNHG14 |
| Synonyms | NA |
| Region | GRCh38_15:24978583-25419462 |
| Ensemble | ENSG00000224078 |
| Refseq | NR_146177 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | cancerous tissues,cell line |
| Expression Pattern | up-regulated |
| Function Description | SNHG14 expression was up-regulated in cancerous tissues from pancreatic cancer patients. |
| Pubmed ID | 31513352 |
| Year | 2019 |
| Title | LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613. |
External Links
| Links for SNHG14 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |